The company said total revenues were $5.1 billion in Q2 2024, compared with $5.2 billion in Q2 2023, and net earnings were $1.8 billion, or $3.10 per diluted share, in Q2 2023, compared with $1.6 billion or $2.71 per diluted share.

1. 01

   The company said total revenues were $5.1 billion in Q2 2024, compared with $5.2 billion in Q2 2023, and net earnings were $1.8 billion, or $3.10 per diluted share, in Q2 2023, compared with $1.6 billion or $2.71 per diluted share.

2. 02

   Aflac said pretax net investment gains were $696 million in Q2 2024, compared with $555 million in Q2 2023. The company cited $649 million in net gains from derivatives and foreign currency and $19 million in higher credit loss allowances as part of those results.

3. 03

   The company said it held $6.1 billion in cash and cash equivalents for stress conditions as of June 30, 2024, which includes the Parent Company's target minimum amount of $1.8 billion.

4. 04

   Aflac said it committed $400 million to Aflac Ventures, of which about $280 million had been funded as of June 30, 2024. The company also said Aflac U.S.'s FHLB borrowing balance was $760 million on the same day.

Key figures

Quarter ended June 30, 2024

Revenue

$5.1B

Net income

$1.8B

EPS

$3.10

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.